AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2012
May 16, 2012
31982_dirs_2012-05-16_3b399128-2aad-4947-8f07-964b4fc0d902.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2011-09-22
Reporting Person: Hahn Timothy Jon (SVP, Manufacturing & PD)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 20000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options-right to buy | $1.42 | 2021-09-22 | Common Stock (200000) | Direct | |
| Options-right to buy | $1.28 | 2022-03-01 | Common Stock (150000) | Direct |
Footnotes
F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.